India  
 
NewsR.in

Lantern Advances Breast Cancer Drug Candidate With FDA Clearance For Early-Stage Trial

Upworthy Monday, 5 May 2025 ()
The U.S. Food and Drug Administration (FDA) on Monday cleared Lantern Pharma Inc.’s (NASDAQ:LTRN) Investigational New Drug Application (IND) for a Phase 1b/2 trial for LP-184 in triple-negative breast cancer (TNBC). The dual approach in the clinical trial is designed to evaluate LP-184 in…
0
shares		ShareTweetSavePostSend
 

You Might Like


Related videos from verified sources

Pressure mounts on Government over cancer-linked drug [Video]

Pressure mounts on Government over cancer-linked drug

Pressure is mounting on the Government after over 100 women came forward to ITV News, believing they were exposed to Diethylstilbestrol, a controversial drug linked to cancer. Prescribed on the NHS for..

Credit: ODN     Duration: 00:34Published
Ex-Philippine President Duterte Faces ICC in Drug War Trial | Duterte’s Full ICC Hearing Day 1 [Video]

Ex-Philippine President Duterte Faces ICC in Drug War Trial | Duterte’s Full ICC Hearing Day 1

Ex-Philippine President Rodrigo Duterte appears before the International Criminal Court (ICC) as he faces charges related to his controversial war on drugs. In this historic trial, the ICC examines..

Credit: Oneindia     Duration: 25:55Published